Ignite Creation Date:
2024-05-06 @ 6:50 PM
Last Modification Date:
2024-10-26 @ 2:55 PM
Study NCT ID:
NCT05795595
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2023-03-21
Brief Title:
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
Sponsor:
CRISPR Therapeutics AG
Organization:
CRISPR Therapeutics
Organization Data
Organization:
CRISPR Therapeutics
Class:
INDUSTRY
Study ID:
CRSP-ONC-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CRISPR Therapeutics AG
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None